Paper List

Neziha Senem Arı, Ayşe Çakır Gündoğdu, Neslihan Meriç, Orhan Özatik

Background Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed in oncology settings, yet their direct effects on endometrial cancer cell fate and survival signaling remain unclear....

Yusi Aveva Xu, Eunju Choi, Celia C. Y. Wong-Meli, Maria Borjas, Fei Fei, Sarah Mann, Wenyue Jin, Lenna Dawkins-Moultin, Di Lun, Qian Lu

Purpose Breast cancer is the second most prevalent cancer among women in the United States. Rural breast cancer survivors (RBCS) face unique challenges because geographical isolation limits access to ...

Wenjie Yang, Chenxi Li, Yuheng Niu, Xin Jiang, Zhifang Ma

Background: Clear cell renal cell carcinoma (ccRCC) is the most prevalent and aggressive subtype of renal cell carcinoma, characterized by high recurrence rates and unfavorable prognosis. Identificati...

Nicole Marinucci, Naomi Moy, Natasha Koloski, Gerald Holtmann

Background Bowel cancer remains a leading cause of cancer‑related mortality in Australia, with rural and remote populations experiencing a disproportionate burden due to later‑stage diagnosis and pers...

Simona Pagliuca, Vincent Alcazer, Mélanie Gaudfrin, Nicole Raus, Anne Huynh, Raynier Devillier, Arda Dumaz, Ashwin Kishtagari, Lukasz Gondek, Mark Juckett, Suresh Kumar Balasubramanian, Marie Robin, Ibrahim Yakoub-Agha, Edouard Forcade, Claude Eric Bulabois, Jean-Baptiste Méar, Patrice Chevallier, Cristina Castilla Llorente, Xavier Poiré, Michaël Loschi, Johan Maertens, Stéphanie Nguyen, Frédéric Baron, Etienne Daguindau, Natacha Maillard, Florent Malard, Alice Aarnink, Maud D’Aveni-Piney, Marie Thérèse Rubio, Francesca Ferraro, Valeria Visconte, Tobias Lenz, Carmelo Gurnari, Jaroslaw Maciejewski

Allogeneic hematopoietic cell transplantation (allo-HCT) remains the only curative option for many hematologic malignancies, yet transplant-related toxicity and relapse continue to constrain long-term...

Wang Zhe, Xiong Yan

Radiotherapy (RT) is integral to the management of head and neck squamous cell carcinoma (HNSCC), yet no validated biomarker exists to predict which patients benefit most. Lactylation, a metabolic pos...

Sara Damiani, Priscilla Guglielmo, Guya Mansi, Sara Calzolai Lettieri, Giulia Giacoppo, Demetrio Aricò, Lucia Setti, Alessia Artesani, Giovanni Lughezzani, Angelo Porreca, Antonio Selvaggio, Laura Evangelista

Objective. Radiolabelled PSMA PET/CT has demonstrated high diagnostic accuracy in staging patients with intermediate-risk prostate cancer (PCa). However, its role on long-term prognosis and outcome pr...

Tânia R. Dias, Beatriz Almeida, Pedro Cruz, Mário Sousa Pimenta, Manuel Morais, Luís Rocha, Jose Manuel Martinez, Ana Luísa Teixeira, Júlio Oliveira, Francisca Dias, Rui Medeiros

Cancer patients are at increased risk of severe COVID-19 outcomes. Understanding their immunological response to SARS-CoV-2 mRNA vaccination is essential for identifying molecular biomarkers that can ...

Li Ranfei, Wang Sirui, Yang Qiying

CRISPR-Cas9 screening enables systematic identification of gene dependencies across diverse cancer cell lines. However, distinguishing lineage-specific vulnerabilities from broadly essential genes rem...

Yutong Zhao, Xinqiang Zhang#, Xiaoshen Wang, Zejun Jiang, Jinzhi Wang, Haonan Xiao, Guanzhong Gong, Yong Yin

Background Left-sided breast cancer radiotherapy poses a challenge in balancing target coverage with the sparing of critical cardiac substructures. A novel hybrid technique - RapidArc Dynamic (RAD) - ...